US Ramps Up Tomahawk Production After Depleting a Third of its Arsenal
Article excerpt
The United States has just launched one of the largest industrial rearmament operations in recent years. The Navy has awarded Raytheon, an RTX subsidiary, a $22.9 billion contract over seven years to drastically accelerate the production of Tomahawk cruise missiles. The goal is to increase from about 60 units annually to more than 1,000, multiplying current capacity by more than 16 times. The move does not imply that Washington has run "out of weapons," but it does reveal a more uncomfortable problem: inventories of precision ammunition have been depleted much faster than the industrial capacity to replace them. The conflict with Iran has exacerbated an existing vulnerability that is particularly concerning due to a potential simultaneous clash in the Indo-Pacific. The agreement announced on August 17 is extraordinary both in its volume and its duration. The US Navy intends to finance more than 7,000 new, modernized, or recertified Tomahawks during the contractual period, according to Janes. The magnitude allows Raytheon to invest in new facilities, suppliers, and personnel with a visibility that traditional annual contracts did not offer. That is precisely the problem Washington is trying to correct. For decades, the US defense industry optimized capacity for limited wars and relatively small orders. The return of prolonged conflicts and competition with China have shown...
Keep reading with a free account
The rest of this article, and every signal for RTX, is in your free account.
Extracted from this sentence
Raytheon will also increase annual production of AMRAAM to at least 1,900 units and SM-6 to over 500, while Washington promotes new capabilities for Patriot, THAAD, and other defensive systems.
